Ross Feller Casey, one of the nation’s preeminent personal injury law firms, is actively pursuing lawsuits across the U.S. involving a type of cancer known as Breast Implant-Associated Anaplastic Large Cell Lymphoma, or BIA-ALCL.
As the name implies, BIA-ALCL is linked to breast implants, which have been shown to greatly increase the risk of developing this rare type of non-Hodgkin’s Lymphoma.
In 2016, the World Health Organization designated BIA-ALCL as a T-cell lymphoma that can develop following breast implants. A year later, the FDA recognized the WHO’s designation that BIA-ALCL can occur after receiving breast implants.
A recent study from a leading U.S. medical journal found that breast implants are associated with increased risk of breast ALCL, but the absolute risk has not been determined.
The FDA announced in February 2019 that the number of women who have developed the disease continues to rise and stands at 457. Nine in the U.S. have died from BIA-ALCL.
BIA-ALCL is not breast cancer and can occur in many different parts of the body, including the lymph nodes and skin.
Manufactures of the breast implants include Mentor/Johnson & Johnson, Allergan/Actavis, and Sientra.
In April 2018, Ross Feller Casey filed what is believed to be the first lawsuit in the nation against Johnson & Johnson and its subsidiaries relating to BIA-ALCL. The suit was brought on behalf of Renee Cashen, 45, of Ashville, Ohio, who developed anaplastic large cell lymphoma eight years after having surgery to implant MemoryGel® SILTEX® implants, made by Mentor Worldwide (read about the case).
The implants that have shown to increase risks of BIA-ALCL can be either silicone gel or saline with either a textured or smooth surface, although findings suggests that the textured variety have led to the condition far more often.
It can take up to 10 years for BIA-ALCL to develop. Patients who develop the disease typically undergo surgery to remove the implant, while others may be treated with radiation and chemotherapy.
Learn more: Frequently asked questions about BIA-ALCL
How is BIA-ALCL diagnosed?
Once patients have symptoms such as those listed above, doctors collect fluid samples for testing. Positive results include the presence of malignant T-cells.
How Do I Know If I Qualify For A Breast Implant-Associated Anaplastic Large Cell Lymphoma Lawsuit?
You may have a breast implant ALCL cancer lawsuit if you:
What sets Ross Feller Casey apart from other law firms is the fact that we have an on-staff team of leading, Ivy League educated and trained physicians (three of whom are also attorneys) that help litigate even the most complex medical malpractice and BIA-ALCL cases.
Consultations with our experienced attorneys are always free of charge.
If you or a loved one was diagnosed with Breast Implant-Associated Anaplastic Large Cell Lymphoma, you may be entitled to compensation, but your time to file a lawsuit is limited.
You should contact one of the BIA-ALCL lawyers at Ross Feller Casey immediately for a free case evaluation. Ross Feller Casey handles all of its cases, including BIA-ACL lawsuits, on a contingency basis. That means you will pay nothing until a recovery is made in your case.